Findings from researchers within the Canadian Consortium on Neurodegeneration in Aging (CCNA) demonstrate that rates of dementia have steadily increased over the past 7-10 years in Indigenous communities. What’s more, onset is now occurring – on average – 10 years ...
A research team within the Canadian Consortium on Neurodegeneration in Aging (CCNA) has reached a major milestone. Their recent publication – marking the CCNA’s 100th – reveals significant information about an important protein that goes awry in the early stages of Frontotempo...
New research suggests there could be a link between certain kinds of cognitive impairment and a greater risk of falls among seniors. Dr. Manuel Montero-Odasso, professor of medicine and geriatric medicine at Western University and co-lead of Team 12 with the CCNA recently sat ...
To all CCNA members, We wanted to remind you that the NIA and the NINDS are regularly releasing a number of funding opportunities on different areas of research on Alzheimer’s disease and related dementias. Many of these opportunities are open to Canadian researchers an...
“Currently, there are no effective means to treat Alzheimer’s disease or definitely diagnose this condition during life. We have recently shown that the protein, butyrylcholinesterase (BChE) typically presents in high levels in the Alzheimer’s disease brain and is a very speci...
“We’re investigating key factors that affect the practical, psychological, and social lives of Canadian family members who are employed while also providing care to a senior with dementia at home. Our goal is to understand the challenges of this dual role and respond to those ...
On March 27, 2017, a team of researchers within the Canadian Consortium on Neurodegeneration in Aging (CCNA) disseminated the first Indigenous-specific health promotion materials available in Canada According to the team’s principal investigator, Dr. Kristen Jacklin: ...
“Researchers and clinicians must embrace the complexity of dementia to gain a clearer understanding of the whole person and the risks they are confronted with. This approach will have a direct impact on the quality of life and quality of care received by people living with dem...
“While the role of the brain’s blood vessels is increasingly recognized in dementia research, models that capture the normal functioning that occurs in human brains are lacking. In an effort to fill this gap, my lab bioengineered a human vascular model. Scientists will be able...
“Our SYNERGIC Trial will support preventative treatment for dementia by showing how cognition can be improved through combining exercise with cognitive training. This will help to lay out future clinical guidelines for physicians whose patients are at risk of developing dement...